Thyroid disease

Adrenal axis integrity after IV methylprednisolone therapy for thyroid eye disease: a retrospective cohort study

Eur J EndocrinolPublished Retrospective cohort study

Authors' conclusion

In this cohort, adrenal responsiveness to the 250 μg ACTH test 7-10 days after completion of IVMP was preserved in all patients, suggesting that early post-treatment secondary adrenal insufficiency is uncommon. Although reassuring, these results should be interpreted cautiously, and clinicians should continue to rely on clinical judgment, supported by biochemical testing when indicated.

Study context

Population
Adults with active moderate-to-severe thyroid eye disease (TED) treated with intravenous methylprednisolone (IVMP), Department of Endocrinology and Metabolic Diseases, University General Hospital of Larissa, Greece115 tested
Participants
127 adults
Outcome
Hypothalamic-pituitary-adrenal (HPA) axis integrity on 250-μg ACTH(1-24) stimulation test; peak cortisol ≥18.1 μg/dL (≥500 nmol/L) indicative of adrenal sufficiency
Follow-up
7-10 days after final IVMP dose
Methodological detailsobservational, single-centre, 12 patients excluded due to unavailability of testing or contraindications
  • Observational
  • Single-centre
  • 12 patients excluded due to unavailability of testing or contraindications

Main finding

As reported in the abstract

Adrenal sufficiency on ACTH stimulation test

Adequate cortisol response at 30 min

93%

Met sufficiency threshold at 60 min

100%

Observational data: associations, not effects.

Further findings

Baseline cortisol ≥18.1 μg/dL among patients tested · 7-10 days after final IVMP dose

Baseline cortisol ≥18.1 μg/dL
15 (13%)
  • 115 patients tested

Adequate cortisol response at 30 min post-ACTH

Adequate cortisol response at 30 min
93%

Patients with baseline cortisol <5 μg/dL (150 nmol/L)

All patients with baseline cortisol <5 μg/dL demonstrated intact adrenal function on dynamic testing

Original publication

Adrenal axis integrity after IV methylprednisolone therapy for thyroid eye disease: a retrospective cohort study. Eur J Endocrinol. Published 15 May 2026. doi:10.1093/ejendo/lvag077

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.